A rapid, lateral flow immunoassay intended for the in-vitro simultaneous qualitative detection and differentiation of nucleocapsid antigen from SARS-CoV- 2, Influenza A, and Influenza B directly from nasopharyngeal swab specimens. The Status COVID-19/Flu Test is only for use under FDA EUA.